Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » About Us » Our Partners

Our Partners

Print
To learn more about our partners, please click on the logos or links below, or contact us directly for an introduction or to learn how you can become a partner. 


Annual Sponsors
 
Suzhou Industrial Park (SIP) Bio Bay is located in the southwest of SIP Dushu lake high education town. Suzhou Industrial Park, the biggest cooperation program between China and Singapore, is committed to develop into a high-tech industrial park with international competitiveness and a modern, international garden-like township. SIP Bio Bay plays a key role as the innovation base for Suzhou Industrial Park to cultivate biotechnology industry and also an innovation platform for the booming of biotechnology and nanotechnology development of both Suzhou city and China. www.biobay.com.cn/


Johnson & Johnson is a broad-based company with a strong vision, a culture of caring, and the resources to invest in the future to take the health and well being to a new level for people throughout the world. Janssen Pharmaceutical China R&D and SA is a major hub in Johnson & Johnson’s family of pharmaceutical focused R&D organizations. Our vision is to be a first-class research and development group capable of efficiently and effectively discovering, developing, and registering innovative healthcare solutions for patients in China, Asia-Pacific region and worldwide. www.jnj.com


Foley is a highly regarded, national law firm providing client-focused, industry-specific services that result in high-value legal counsel for our clients. Foley is dedicated to the interests of our clients, our people, and our communities. We strive to address their needs and meet their expectations efficiently and effectively — and we do so with integrity, insight, and innovation.
www.foley.com

Established in 1989, OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm. OrbiMed manages over USD$7 billion assets, including several PE/VC funds, hedge funds and mutual funds. Since the inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 150 private companies across a wide range of therapeutic categories and stages of development, 85 of which have been either listed or acquired. OrbiMed has continued strong performance in public equity as well, with ~27×cumulative return in the past 20 years. OrbiMed’s investment team includes over 60 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed Asia, with offices in Shanghai and Mumbai, manages OrbiMed Asia Partners (OAP), the first pan-Asia healthcare and life sciences-dedicated private equity fund, with approximately USD$200 million under management. OAP has made investments in 15 companies. www.orbimed.com.

Official Partners

BayHelix is an organization of leaders of Chinese origin in the global life sciences and healthcare community. We aspire to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience. BayHelix is a non-profit organization and its membership is by-invitation-only. www.bayhelix.org
BioCentury Publications, Inc., www.biocentury.com provides essential biopharma industry intelligence from five offices in the U.S. and Europe. For more than 18 years, a global audience of biotech and pharmaceutical executives and investors has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, data products and collaborative industry conferences in the U.S., Europe and Asia. BioCentury's titles include the flagship BioCentury, the Bernstein Report on BioBusiness; SciBX: Science-Business eXchange, a translational science joint publishing venture with Nature Publishing Group; and BioCentury Extra, online daily news covering breaking developments BioCentury also markets its BCIQ: BioCentury Online Intelligence, an online business intelligence resource. In September 2010, the company launched BioCentury This Week, the first weekly biotech public affairs TV program to be broadcast in major U.S. television markets, a partnership with the Gannett-owned CBS affiliate W*USA Channel 9 in Washington, D.C. The BioCentury This Week TV show website continuously streams TV content at www.biocenturytv.com.

 

Nature is the world's foremost weekly scientific journal and is the flagship journal for Nature Publishing Group (NPG). Launched in 1869, its original mission statement still leads the Group as we develop publications, explore opportunities arising from new technology and serve a growing audience of readers.NPG publishes journals and online databases across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 30 journals are published in association with prestigious academic societies. www.nature.com


Supporting Partners
Beijing Pharma and Biotech Center (BPBC) is the principal health research agency of the Beijing Local Government; it is a component of Beijing Municipal Commission for Science and Technology (BMCST). Established in 1996 and initially function as the development and implementation of Beijing Government Grants Policy, BPBC serves as the focal point for advisory industrial policy, mandatory project management for government and international bridge between Chinese Biotech & Pharmaceutical Industry and the rest of the world. BPBC is composed of five divisions: Project Management, Strategy Study, Business Liaison and International Affairs, General Administration and Financial Management Divisions. www.newlife.org.cn/en
BIOCOM is a leading biotechnology industry association with over 550 leading life science companies from Southern California as members. BIOCOM's initiatives focus on capital formation, public policy, resource development and scientific discovery and development. They have recently launched a special program to educate and connect U.S.-based life science companies with low cost resources and services available in China. www.biocom.org
Chinese-American BioPharmaceutical Society (CABS) is a not-for-profit, non-political, non-religious professional organization headquartered in San Francisco, California. With the rapid development of bio/pharmaceutical industry in China, more and more people, regardless of their ethnic backgrounds, are looking toward China for business and scientific opportunities. Recognizing this trend, CABS was established not only to educate the public with the progress in biotech and pharmaceutical fields, but also to serve the Bio/Pharmaceutical professionals who are either with Chinese heritage or with professional interests in China. The majority of CABS members are Chinese scientists, entrepreneurs and students/postdocs in biomedical sciences, working in San Francisco Bay Area bio/pharmaceutical industries, universities, and research institutes. The CABS membership is open to the public.
 
 
The Chinese Biopharmaceutical Association (CBA) is a non-profit organization made up of professionals who have an interest in bio-pharmaceutical research and/or technology development. CBA was established in 1995 and its headquarters are located in the State of Maryland, which is adjacent to the U.S. capital city of Washington D.C. The majority of CBA members are Chinese scientists, researchers, or professors. They work in government agencies, universities, research institutes as well as in the biotechnology and pharmaceutical industries. Some are conducting pioneering research with the National Institutes of Health (NIH), whereas others are directly involved in the government regulatory process as officers of the Food and Drug Administration (FDA) or in the field of intellectual property as patent attorneys or as patent examiners with the Patent and Trademark Office (PTO). http://www.cba-usa.org/cba_home.htm
 
 
ChinaSF is an economic development platform supporting business exchange between China and San Francisco.  It is a partnership between the City of San Francisco Mayor's Office and the San Francisco Center for Economic Development. With an office in Shanghai and in San Francisco, it is able to provide bi-lingual cross-border support to Chinese businesses interested in expanding business operations to North America. In particular, it can connect Chinese businesses to necessary professional service resources, business partners and can help navigate government regulations. This initiative builds on the already strong cultural exchange between San Francisco and China by providing a systematic support for strengthening business and economic relations. www.sfced.org/international/chinasf
Guangzhou Biotechnology Center (namely Biomedical work group of Guangzhou Municipal Government) under the jurisdiction of the Biotechnology Steering Group and the Sciences &Technology Bureau of Guangzhou Municipal Government is a service agency specializing in biotechnology and medicine industry. Its key missions are to develop the biotechnology and medicine industry of Guangzhou and to accelerate the transfer of S&T achievements and parallel cooperation and exchange. www.gzbio.net
 

Hong Kong Science and Technology Parks Corporation (HKSTP) is a statutory body set up by the Government of the Hong Kong SAR to promote and facilitate the transformation of Hong Kong into Asia’s hub for technology innovation. The Corporation supports a number of technology industries engaging in cutting-edge research and development, including the Life Science and Biotechnology industries, and offers a comprehensive range of facilities and services to address the needs of companies at various stages of development.
www.hkstp.org 

Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) is a 501(C) (3) nonprofit organization founded in early 2002 by professionals and scholars from local Chinese community in San Diego. We invite all scholars, students and professionals with any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry to join us as members of SABPA. www.sabpa.org/web/index.php 

The Sino-American Pharmaceutical Professionals Association (SAPA) was founded in 1993 as a non-profit organization with its headquarters in the Greater New York area (NJ/NY/CT). SAPA has grown rapidly to become one of the most active and well-recognized professional organizations in the United States with over 4000 members. SAPA's missions are to facilitate the advancement of pharmaceutical science and biotechnology, to contribute to public health education, to foster personal and professional career development, and to promote scientific exchange and business cooperation between the USA and China. In addition to the Greater New York area, SAPA has established regional chapters in New England (SAPA-NE), Greater Philadelphia (SAPA-GP) and West Coast (SAPA-WEST), as well as Shanghai Club (SAPA-Shanghai). www.sapaweb.org  


Media Partners
Bioon are the leading life science portal in China. And professional registered members have more than 500 thousand; special 70% members are the master's -and doctoral qualifications. Our enterprises’ customers are more than 11 thousand, such as Invitrogen, Promega, Qiagen, Sigma, Pall. As the leading service- provider in China, we are committed to enhance the competition of our customers in life sciences. The following pipelines are our mature businesses: (1) www.bioon.com commitment to the field of life sciences media and brand promotion; (2) www.bioon.com.cn focused on our customers’ products -promotion, display and rankings, such as equipments, consumables, reagents and antibodies; Addition, we collected and sorted the serial of databases -including China lab database, professor database and region -based registered members database. These databases are the strong support and tool for customers marketing activity and marketing survey & analysis. Now, Bioon.com has become the preferred options to life sciences’ customers for professional seminar & training, targeting product promotion, brand -improvement and marketing survey & analysis. of professional customers in China. www.bioon.com
China is already the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology. ChinaBio® Today focuses exclusively on the rapidly evolving biotech industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market.  www.chinabiotoday.com
Interfax China is a member of the Interfax International Information Group. Interfax Group provides news and other information products that are essential for decision-makers in politics and business. Since early 1990s, Interfax has been the main provider of up-to-date news from Russia and countries of the former Soviet Union. We are the most frequently quoted source of information on the region. Over the past few years, Interfax has also become a leading provider of political and business news from China and emerging markets of Central Europe. www.interfax.cn
PharmAsiaNews.com is an online portal providing news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and other nations of the Pacific Rim. PharmAsiaNews.com leverages the editorial excellence of "The Pink Sheet" -- the leading information source for the U.S. pharmaceutical industry since 1939. Subscribers get original on-the-ground reporting from news bureaus across Asia, guest columns, exclusive interviews, news summaries, English translation summaries of Chinese- and Japanese-language news, and aggregated content from around the globe. Free 30-day trial.www.PharmAsiaNews.com


Healthcare Executive, established in December 2008, is a monthly magazine focused on the pharmaceutical industry. It is hosted by Chinese Pharmaceutical Enterprises Association and ZhuoXin Medical Media Group and supported by a team consists of senior medical media people, and positioned to a “the news and resource center in the pharmaceutical industry”. Its readers are mostly entrepreneurs, investors, and people work at the supervision and services organizations in this industry.
In terms of the content, Healthcare Executive has been realistic, reports on the whole industry chain, discovers the experiences and concerns, strategies and execution, growth and missions of industry entrepreneurs and forms the most abundant and comprehensive database of the growth cases of the industry companies. It combines global vision and local intelligence, being open-minded and concentrated at the same time, brings the most and profound understanding to its readers, building new medical media languages. Healthcare Executive also presents the first hand industry news on the development of new products, production and circulation, supervision and services organizations, capitals, helps people update information quickly, discover values and make progress. Our vision is that every one serves in pharmaceutical industry reads Healthcare Executive. For now, we’re working hard to make each issue a great excitement.www.he-cn.com

Login